Skip to main content

Table 3 Empiric therapy in patients with candidemia (N = 115)

From: Evaluation of Candida bloodstream infection and antifungal utilization in a tertiary care hospital

Variables n(%)
Time to start empiric therapy with antifungal after blood culture obtained (hours)
24 51 (44.3)
48 20 (17.4)
72 16 (13.9)
96 7 (6.1)
120 5 (4.3)
No use of antifungal drug 16 (13.9)
Appropriate empirical antifungal treatment according to antifungal susceptibility test result
No 21 (18.3)
Yes 94 (81.7)
Adequate dose according to institutional protocola
Caspofungin 28/28 (100.0)
Micafungin 31/41 (75.6)
Anidulafungin 5/8 (62.5)
Fluconazole 12/49 (24.5)
Amphotericin B liposomal 20/21 (95.2)
Voriconazole 4/5 (80.0)
  1. Category variables presented by absolute and relative frequencies
  2. anumber of cases observed/number of cases using antifungal drug
\